论文部分内容阅读
血管紧张素转换酶抑制剂(ACEI)治疗高血压,近年颇受临床重视,已有不少学者主张作为首选降压药。依那普利(enalapril,又称苯酯丙脯酸)为第二代ACEI,在国外已广泛应用于临床,在国内近年亦已开始生产。本文应用前瞻性研究,观察了依那普利胶囊治疗原发性高血压的临床疗效。
Angiotensin converting enzyme inhibitor (ACEI) for the treatment of hypertension, clinically important in recent years, many scholars have advocated as the preferred antihypertensive drugs. Enalapril (also known as phenylpropion) is the second generation of ACEI, which has been widely used in clinic abroad and has been produced in China in recent years. In this study, we prospectively studied the clinical efficacy of enalapril in the treatment of essential hypertension.